The chemical class denoted as CaBP5 inhibitors constitutes a distinctive group of organic compounds recognized for their capacity to selectively target and modulate the activity of the calcium-binding protein 5 (CaBP5). This particular protein, CaBP5, exerts a pivotal influence within cellular environments by participating in intricate calcium-mediated signaling pathways that intricately regulate various physiological processes. The class of CaBP5 inhibitors is typified by their intricate molecular structures, which are meticulously engineered to interact with key regions of CaBP5, thereby impeding its ability to bind to calcium ions effectively or to interact with other pertinent protein partners. This engagement at the molecular level consequently disrupts the normative functional role of CaBP5, inducing alterations in downstream signaling cascades that fundamentally rely on calcium-dependent mechanisms.
The rationale underlying the development of these inhibitors stems from the intricate interplay between CaBP5 and cellular calcium dynamics. In essence, these inhibitors serve as invaluable tools for the dissection of intricate biochemical networks, elucidating the delicate balance that governs calcium signaling in diverse cellular contexts. Through experimental investigations into the interactions between CaBP5 inhibitors and the protein itself, researchers gain a deeper appreciation of the intricate structural motifs and chemical moieties that dictate the binding affinity and specificity of these inhibitors. This intricate dance of molecular recognition unlocks a deeper understanding of how CaBP5 functions as a linchpin in the broader tapestry of cellular communication. The exploration of CaBP5 inhibitors transcends the realm of a singular protein-target interaction, extending into the realm of broader scientific inquiry. By harnessing the power of these inhibitors, researchers unravel the mechanisms that underpin the communication between cellular components, which ultimately culminate in the orchestration of complex biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII), which is closely related to CAPBIt has been used in research to study the role of CaMKII and CAPB5 in various cellular functions. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 is another calmodulin inhibitor that indirectly affects CAPB5 function. It competes with calmodulin for binding to Ca2+ and thus interferes with Ca2+-dependent signaling pathways. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmidazolium is a compound that inhibits calmodulin and, by extension, may affect CAPB5 signaling. It has been investigated for its potential role in modulating intracellular calcium levels. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a calpain inhibitor that can indirectly affect CAPB5 activity by interfering with calpain-mediated processes. Calpains are calcium-dependent proteases, and their activity can impact CAPB5 functions. | ||||||
Flupirtine Maleate | 75507-68-5 | sc-218512 | 10 mg | $103.00 | 1 | |
Flupirtine may have some effect on CAPB5-mediated signaling pathways. It has been studied for its potential neuroprotective and analgesic properties. | ||||||
Trifluoperazine Dihydrochloride | 440-17-5 | sc-201498 sc-201498A | 1 g 5 g | $57.00 $101.00 | 9 | |
Trifluoperazine inhibits calmodulin, potentially affecting CAPB5-related cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A-23187 is a calcium ionophore that can increase intracellular calcium levels. While not a direct CAPB5 inhibitor, it can impact CAPB5-mediated pathways by altering calcium signaling. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, like nifedipine, is a calcium channel blocker that can influence CAPB5 pathways by modulating calcium ion concentrations. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is a compound that can inhibit various calcium-binding proteins, including calmodulin. Its potential effects on CAPB5-mediated functions have been investigated. | ||||||